A blood-based multi-pathway biomarker assay for early detection and staging of Alzheimer's disease across ethnic groups.
Yuanbing Jiang, Hyebin Uhm, Fanny C Ip...
https://pubmed.ncbi.nlm.nih.gov/38183344/Actively Recruiting
Age: 60Years - 75Years
All Genders
Healthy Volunteers
ID07347574
Community-Based Study in Hong Kong to Detect Early Alzheimers Using Blood Tests and Brain Imaging in Adults Aged 60 to 75
Led by Hong Kong University of Science and Technology · Updated on 2026-07-08
2500
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Population aging is a significant global challenge, with 1.6 billion people expected to be over 65 by 2050. Aging is the main risk factor for many chronic diseases, including Alzheimers disease AD. Hong Kong, with one of the highest life expectancies and a large elderly population, faces a heavy burden of dementia care. This community-based study aims to establish a cohort of elderly individuals in Hong Kong, focusing on early detection of Alzheimers and related cognitive conditions through clinical, cognitive, biomarker, and neuroimaging measures.
CONDITIONS
Brief Title
NeuroCare Community Project: A Community Based Prospective Observational Study for Early Alzheimer's Detection in HK
Research Team
N
Nancy Ip, PhD
K
Kin Ying Mok, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here